Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride 5 mg effectively reduces urinary symptoms and PSA levels in men with enlarged prostates, with few sexual side effects.

Terazosin and finasteride effectively treat BPH, but combining them adds no extra benefit.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

Testosterone therapy increases bone density in older men with low testosterone levels.

Testosterone with or without finasteride doesn't improve thinking skills in older men with low testosterone.

Selenium and vitamin E supplements have mixed effects on prostate cancer risk and may not be beneficial for everyone.

A hair wrapped tightly around an infant's toe caused severe damage, requiring early removal and possibly surgery to prevent worse outcomes like amputation.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

The questionnaire effectively measures men's perceived hair growth and can distinguish between different treatments and dosages.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Finasteride use doesn't cause sexual dysfunction in men with hair loss.

TURP is the best treatment for BPH, but some patients prefer medications like alpha-blockers and finasteride.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Combination therapy for 9+ months maintains symptom improvements after stopping alpha-blockers or finasteride.

Early diagnosis and treatment of Hidradenitis Suppurativa are important to prevent serious physical and mental effects.

The junction of the inner and outer prepuce with good blood flow is ideal for surgical flaps.

New method measures finasteride in plasma, finds two formulations bioequivalent.

Treatment with 5α-reductase inhibitors is linked to a delay in prostate cancer diagnosis and may affect survival rates.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Dutasteride may help treat prostate cancer by causing cancer cells to shrink and die.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.